Pemphigus vulgaris, although it is a rare disease, has always been of interest to medicine because of its rarity. Its treatment is long-term and, although today it is detected early, it can still cause death.
As a rare skin disease, its distribution in the world is also variable. According to epidemiological studies, there are countries like Israel where five people out of every one hundred thousand suffer from it in a year, while in England it is only one affected every one hundred thousand inhabitants a year.
In pediatric age, the risk of pemphigus vulgaris is minimal. The bulk of cases appear in very old people, and with a tendency to become chronic. There are no differences in the number of patients in the world between men and women.
What is pemphigus vulgaris?
It is an autoimmune disease, that is to say, that the own antibodies attack structures of the organism that they do not recognize, it is not contagious. Those who suffer from it cannot transmit it to others by contact or closeness.
The skin blisters caused by pemphigus vulgaris are not fatal in themselves, but they carry certain complications that can eventually lead to death when treatment is not instituted. Among the most frequent complications we can name:
- Dermal infections
- Sepsis: is the extension of the infection to the blood.
- Malnutrition: due to feeding difficulties due to mouth blisters.